Equity Details
Price & Market Data
Price: $18.74
Daily Change: +$1.29 / 6.90%
Daily Range: $17.43 - $19.02
Market Cap: $0
Daily Volume: 171,159
Performance Metrics
1 Week: -10.50%
1 Month: -10.50%
3 Months: -10.50%
6 Months: -10.50%
1 Year: -10.50%
YTD: 9.01%
About Odyssey Therapeutics, Inc. (ODTX)
Your daily market report for Odyssey Therapeutics, Inc. (ODTX). Price: 18.74, daily change: +$1.29 / 6.90%. Market cap: N/A. Full performance analysis from YTD to 52-week.
Details
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5); OD-003, a protein therapeutic designed to agonize tumor necrosis factor receptor 2 selectively on Treg; a TSLP/IL-33 bispecific antagonist; an oral small molecule interleukin-1 receptorassociated kinase 4 scaffolding inhibitor; and a small molecule inhibitor of IRF5. The company was incorporated in 2021 and is headquartered in Boston, Massachusetts.